Tag : biological markers

Biomarkers

Canary Speech Launches Canary Ambient™

PR Newswire
Canary Ambient™ enables actionable insights into patient-clinician dialogues, tracking speech patterns, and delivering real-time evaluations of cognitive and behavioral health conditions Canary Speech, a leader...
Biomarkers

Lunaphore announced partnership with Discovery Life Sciences

PR Newswire
Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMET™, a best-in-class spatial biology platform,...
Biomarkers

Almaden Genomics Launches Data Management, Informatics Services business

Business Wire
Almaden Genomics has launched a new Data Management and Informatics Services business to support its bioinformatics and computational biology solutions. This expansion underscores Almaden’s commitment...
Biomarkers

Canary Speech Receives Patent for Paired Neural Networks Technology

PR Newswire
New patent is a major advancement in the capabilities of speech analysis and has the potential to revolutionize various industries including healthcare and customer service...
Biomarkers

Lunit Joins Roche’s Digital Pathology Open Environment

PR Newswire
Lunit’s AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche’s navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing Lunit (KRX:328130.KQ), a...
Biomarkers

Dxcover names first US Scientific Advisory Board Member

Business Wire
Luke Pike MD, DPhil, Radiation Oncologist, joins Dxcover Scientific Advisory Board to advise the company on brain cancer diagnostic early detection clinical applications Dxcover Limited, a...
Biomarkers

Noetik Secures $40 Mn Series A to Advance Precision Cancer Therapies

Business Wire
Noetik, an AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced today that it closed an oversubscribed...
Biomarkers

Jeffrey Elliott Appointed to Quanterix’s Board of Directors

Business Wire
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultra-sensitive biomarker detection, today announced that it appointed Jeffrey Elliott to its Board...